The Pathway of US11-dependent Degradation of MHC Class I Heavy Chains Involves a Ubiquitin-conjugated Intermediate
Overview
Authors
Affiliations
The human cytomegalovirus protein, US11, initiates the destruction of MHC class I heavy chains by targeting them for dislocation from the ER to the cytosol and subsequent degradation by the proteasome. We report the development of a permeabilized cell system that recapitulates US11-dependent degradation of class I heavy chains. We have used this system, in combination with experiments in intact cells, to identify and order intermediates in the US11-dependent degradation pathway. We find that heavy chains are ubiquitinated before they are degraded. Ubiquitination of the cytosolic tail of heavy chain is not required for its dislocation and degradation, suggesting that ubiquitination occurs after at least part of the heavy chain has been dislocated from the ER. Thus, ubiquitination of the heavy chain does not appear to be the signal to start dislocation. Ubiquitinated heavy chains are associated with membrane fractions, suggesting that ubiquitination occurs while the heavy chain is still bound to the ER membrane. Our results support a model in which US11 co-opts the quality control process by which the cell destroys misfolded ER proteins in order to specifically degrade MHC class I heavy chains.
NEMF-mediated CAT-tailing defines distinct branches of translocation-associated quality control.
Ennis A, Wang L, Wang X, Yu C, Saidi L, Xu Y bioRxiv. 2024; .
PMID: 39253483 PMC: 11383284. DOI: 10.1101/2024.08.27.610005.
ER-associated degradation in cystinosis pathogenesis and the prospects of precision medicine.
Venkatarangan V, Zhang W, Yang X, Thoene J, Hahn S, Li M J Clin Invest. 2023; 133(19).
PMID: 37561577 PMC: 10541201. DOI: 10.1172/JCI169551.
Battle between Host Immune Cellular Responses and HCMV Immune Evasion.
Manandhar T, Ho G, Pump W, Blasczyk R, Bade-Doeding C Int J Mol Sci. 2019; 20(15).
PMID: 31344940 PMC: 6695940. DOI: 10.3390/ijms20153626.
Schlottmann F, Strauss S, Hake K, Vogt P, Bucan V Int J Mol Sci. 2019; 20(9).
PMID: 31027326 PMC: 6540026. DOI: 10.3390/ijms20092056.
Pump W, Kraemer T, Huyton T, Ho G, Blasczyk R, Bade-Doeding C Int J Mol Sci. 2019; 20(6).
PMID: 30909402 PMC: 6471057. DOI: 10.3390/ijms20061454.